Journal of the National Comprehensive Cancer Network

Title Publication Date Language Citations
HSR23-103: Pancreatic Cancer: The Impact of Early Connectivity and Coordination of Care on Retention and Time to Treat2023/03/31
CLO23-045: A Prospective Interventional Study to Assess the Response of Systemic Chemotherapy in Aggressive, Recurrent Giant Cell Tumor2023/03/31
CLO23-029: An APP-Run Lymphadenopathy Clinic: The Cleveland Clinic Experience2023/03/31
CLO23-035: Expression of PD-L1 Through Evolution Phase From Pre-Invasive to Invasive Lung Adenocarcinoma2023/03/31
QIM23-126: Positive Quality Intervention in Action: Implementation and Value in Practice2023/03/31
QIM23-132: Do EHR-Embedded Clinical Decision Support Tools Reduce Variation in Care? A Pre and Post-Implementation Comparison of Regimen Ordering Variation at a Multi-Site Community Cancer Clinic2023/03/31
EPR23-086: Knowing the Lymphomas of the Legal Amazon: How Do They Differ?2023/03/31
CLO23-052: Risk Factors and Prognosis of Stroke in Gynecologic Cancer2023/03/31
EPR23-085: Prevalence of Substance Use in Cancer Patients at a 5-Year Difference: A Cross-Sectional Study From Nationally Representative Population2023/03/31
QIM23-137: Improving Hematology-Oncology Education in Internal Medicine Residency—A Single Institution Quality Improvement Project2023/03/31
EPR23-078: Analyzing Trends in the Incidence and Mortality of Esophageal Cancer in the United States: A 15-Year Population-Based Study2023/03/31
HSR23-123: Conventional Hydration Versus Short Hydration for Reducing Chemotherapy Induced Nephrotoxicity (CIN) Among Adult Esophageal Cancer Patients at Uganda Cancer Institute, Mbarara – Uganda: An Interventional Study2023/03/31
QIM23-138: Using the Electronic Health Record (EHR) to Capture Structured Oncology Data in Real-Time at the Point-of-Care: A Mayo Clinic Comprehensive Cancer Center (MCCCC) Pilot Study2023/03/31
BPI23-013: Comparison of Modified Patient-Reported Paper G8 and EPIC G4 + 4 With Clinician-Reported Standard G8 to Screen Frailty in Elderly Patients With Cancer2023/03/31
CLO23-049: An Unusual Case Presentation of Severe Idiopathic Multicentric Castleman Disease (iMCD)2023/03/31
HSR23-098: Extensive and Dynamic Signs and Symptoms Prior to Cancer Diagnoses2023/03/31
QIM23-127: Using NCCN Distress Thermometer to Screen Cancer Patients on an Inpatient Oncology Unit2023/03/31
PCL23-125: Volatile Organic Compounds Released by Gastric Tissues as Potential Biomarkers of Gastric Cancer2023/03/31
HSR23-089: Patient Reported Quality of Life (QoL) Among Adults Admitted for Oncology Care in Abu Dhabi, United Arab Emirates (UAE)2023/03/31
BPI23-014: Elevation in the Creatinine With Niraparib: True or False?2023/03/31
CLO23-030: MC200402-Single-Arm Phase 2 Study of the FGFR Inhibitor Futibatinib (Futi) in Combination With Pembrolizumab (Pem) in Patients With FGF19 Expressing Advanced or Metastatic Hepatocellular Carcinoma (aHCC)2023/03/31
CLO23-038: The Impact of Dysbiosis Agents on the Effectiveness of Immune Checkpoint Inhibitors in Advanced Melanoma Patients: A Systematic Review With Meta-Analysis2023/03/31
HSR23-093: Lung Cancer Treatment Utilization Trends: 2019-20212023/03/31
QIM23-147: Predictors of Delay for Initial Oncology Referral and Treatment at a Safety-Net Hospital: A Single Center Analysis2023/03/31
BPI23-007: Characterizing Opioid Prescribing Trends of Medical Oncologists From 2013–20192023/03/31
CLO23-025: Comparison of Outcomes Using NCCN Classification in Two Concurrent Phase III Trials in Intermediate and High Risk Prostate Cancer: Long-Term Data2023/03/31
CGE23-075: Tumor Transcriptomic Profile in Patients (pts) With Synchronous Versus Metachronous Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)2023/03/31
YIA23-002: Evolutionary Pressures Shape Soft Tissue Sarcoma Development and Response to Radiotherapy2023/03/31
CLO23-058: Targeted Axillary Dissection Post Primary Chemotherapy: Data Analysis From a Single Multidisciplinary Unit in South Africa2023/03/31
PCL23-124: The Role of SMAD4/TGFβ Signaling in Tumorigenesis of Pancreatic Ductal Adenocarcinoma (PDAC)2023/03/31